IL6 and Parkinson disease: The Nrf2 pathway regulates the expression of inflammatory biomarkers inducible NO synthase, interleukin 6 (IL-6), tumor necrosis factor-alpha (TNF-α) (22), as well as the microglial function and neuroinflammation as in cases of Parkinson’s disease (23).